BSEInsider Trading / SAST29 Sept 2026 · 29 Sept 2026, 06:18 pm
Intimation of closure of trading window under ther SEBI (Prohibition of Insider trading) Regulation, 2015.
KMS Medisurgi Ltd · 540468
✦ AI Summary
KMS Medisurgi Ltd has announced the closure of its trading window under the SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of its half-yearly financial results.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
KMS Medisurgi Ltd - 540468 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
924b1b71-329f-4e42-ab9f-2e6f4208cfab.pdf
View document text
KMS MEDISURGI LIMITED
Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street,
® Mumbai 400 002 Maharashtra (India)
) CIN: L51397MH1999PLC119118
Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com
Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111
Date: 29.09.2026
BSE Limited
Corporate Relationship Department
Ist Floor, New Trading Ring, Rotunda Building,
P. J. Towers, Dalal Street,
Fort, Mumbai — 400 001
Sub: Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider
Trading) Regulations, 2015
Ref: KMS Medisurgi Limited — Scrip Code: 540468
Dear Sir/Madam,
This is to inform you that pursuant to the provisions of the Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and
the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for
dealing in the securities of the Company shall remain closed for all Designated Persons and
their Immediate Relatives with effect from Thursday, October 1, 2026, and shall remain
closed until 48 hours after the declaration of the duly approved Financial Results of the
Company for the half year ended September 30, 2026.
Accordingly, all Designated Persons and their Inmediate Relatives have been intimated not to
trade in the securities of the Company during the aforesaid period of closure of the Trading
Window.
The date of the Board Meeting for consideration and approval of the Financial Results of the
Company for the half year ended September 30, 2026, will be intimated to the Stock Exchange
in due course, in accordance with the applicable provisions.
You are requested to kindly take the above information on record.
Thanking you,
Yours faithfully,
For KMS MEDISURGI LIMITED
FOR KMS mum_ LUMITED N
Siddharth Kanakia
Managing Director
DIN: 07595098
Place: Mumbai